NMPA Approval

Pazufloxacin Mesilate and Sodium Chloride Injection

Approval Number

国药准字H20090327

Company扬子江药业集团有限公司

Registration Date

July 29, 2019

Drug Information

Generic Name

甲磺酸帕珠沙星氯化钠注射液

Dosage Form

注射剂

Strength

100ml:甲磺酸帕珠沙星0.3g(以C16H15FN2O4计)与氯化钠0.9g

Drug Type

化学药品

Registration Date

July 29, 2019

Company Information

Applicant Company

Company Name扬子江药业集团有限公司

Company Address

泰州市扬子江南路1号

Manufacturing Company

Company Name扬子江药业集团有限公司

Company Address

江苏省泰州市扬子江南路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

甲磺酸帕珠沙星氯化钠注射液 - NMPA 批准文号 | MedPath